Acute respiratory failure

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • AstraZeneca AB Commercial
    TOZORAKIMAB
    2023-507031-38-00 14 countries 2023 n=828
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
AstraZeneca AB Commercial 1 Phase III 1
New trials by year
2023
1
← All indication landscapes